Oppenheimer Asset Management Inc. trimmed its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 4.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 53,415 shares of the medical equipment provider's stock after selling 2,740 shares during the period. Oppenheimer Asset Management Inc.'s holdings in Intuitive Surgical were worth $27,880,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors and hedge funds have also bought and sold shares of ISRG. Bennett Selby Investments LP grew its position in shares of Intuitive Surgical by 3.9% during the fourth quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider's stock valued at $234,000 after purchasing an additional 17 shares in the last quarter. LVW Advisors LLC lifted its stake in Intuitive Surgical by 1.3% in the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider's stock worth $756,000 after purchasing an additional 19 shares during the last quarter. Wesbanco Bank Inc. lifted its stake in Intuitive Surgical by 1.6% in the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider's stock worth $635,000 after purchasing an additional 19 shares during the last quarter. Journey Strategic Wealth LLC increased its position in shares of Intuitive Surgical by 1.9% during the fourth quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider's stock worth $542,000 after acquiring an additional 19 shares during the period. Finally, FSM Wealth Advisors LLC increased its position in shares of Intuitive Surgical by 3.7% during the fourth quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider's stock worth $275,000 after acquiring an additional 19 shares during the period. 83.64% of the stock is owned by institutional investors.
Analyst Ratings Changes
A number of equities analysts have recently commented on the stock. Raymond James raised their target price on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an "outperform" rating in a research report on Friday, January 24th. JPMorgan Chase & Co. raised their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an "overweight" rating in a research report on Friday, January 24th. Citigroup raised their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a "buy" rating in a research report on Friday, January 24th. Barclays raised their target price on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Finally, Jefferies Financial Group raised their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have assigned a buy rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $613.10.
View Our Latest Report on ISRG
Insider Activity at Intuitive Surgical
In related news, EVP Myriam Curet sold 2,401 shares of the business's stock in a transaction on Thursday, February 27th. The shares were sold at an average price of $581.00, for a total transaction of $1,394,981.00. Following the completion of the transaction, the executive vice president now directly owns 353 shares in the company, valued at $205,093. The trade was a 87.18 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Jamie Samath sold 269 shares of the business's stock in a transaction on Monday, February 10th. The shares were sold at an average price of $590.00, for a total transaction of $158,710.00. Following the transaction, the chief financial officer now owns 3,282 shares of the company's stock, valued at $1,936,380. This represents a 7.58 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 8,077 shares of company stock worth $4,620,025 over the last three months. Company insiders own 0.90% of the company's stock.
Intuitive Surgical Trading Up 1.7 %
Shares of NASDAQ:ISRG traded up $9.38 on Friday, hitting $573.15. 2,399,758 shares of the company were exchanged, compared to its average volume of 1,733,598. The firm has a market capitalization of $204.14 billion, a P/E ratio of 89.42, a price-to-earnings-growth ratio of 5.85 and a beta of 1.39. The stock's 50 day moving average price is $569.87 and its 200 day moving average price is $528.64. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00.
About Intuitive Surgical
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Read More

Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.